Cadpride MP 2mg/500mg/15mg Tablet SR
Marketer
Caddes Life Sciences
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Cadpride MP 2mg/500mg/15mg Tablet SR
Metformin-pioglitazone-glipizide extended-release tablets (2mg/500mg/15mg) are a triple-combination medication managing blood glucose. This medication, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, consequently reducing blood sugar. Dosage and duration should strictly follow your physician's instructions. Administer with food to minimize gastrointestinal discomfort. If a dose is missed, take it immediately unless the next dose is imminent; in this case, omit the missed dose and resume the usual schedule. Never double the dose. Overdosage risks hypoglycemia. Concurrent use with other antidiabetics, alcohol, or meal skipping may precipitate hypoglycemia; regular blood glucose monitoring is vital. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiation, disclose any kidney, liver, or cardiac conditions to your doctor. Pregnant or lactating individuals require prior medical consultation. Kidney function tests will be assessed before treatment begins. Limit alcohol consumption as it may heighten side effect risk.
Uses of Cadpride MP 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Cadpride MP 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Cadpride MP 2mg/500mg/15mg Sustained-Release Tablets should be administered with a meal.
Common Side effects of Cadpride MP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Cadpride MP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Cadpride MP 2mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
How Cadpride MP 2mg/500mg/15mg Tablet SR works:
Cadpride MP SR tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action improves blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Cadpride MP 2mg/500mg/15mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Cadpride MP 2mg/500mg/15mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Cadpride MP tablets (2mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Cadpride MP 2mg/500mg/15mg SR tablets cautiously, as dosage modification may be necessary. For patients with severe kidney disease, this medication is contraindicated. Consult a physician. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Cadpride MP 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. Cadpride MP 2mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Cadpride MP 2mg/500mg/15mg Tablet SR :
Should you forget to take a Cadpride MP 2mg/500mg/15mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cadpride MP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently